Article in Magnetic resonance in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 1 institution in 1 country.
Tanner M NicklesDepartment of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-4322-2431
Yaewon KimDepartment of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-1016-1572
Philip M LeeDepartment of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-5783-1599
Hsin-Yu ChenDepartment of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-2765-1685
Michael OhligerDepartment of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0001-6878-8189
Robert A BokDepartment of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
Zhen J WangDepartment of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
Peder E Z LarsonDepartment of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-4183-3634
Daniel B VigneronDepartment of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0001-5795-8699
Jeremy W GordonDepartment of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-2760-4886
University of California, San Francisco · US
Funding
TR&D3: Open-Source Tools for Processing Hyperpolarized MR DataP41EB013598 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Daniel B Vigneron · 2011 to 2026
$19.9M
Supplement for Development and Translation of Specialized Hyperpolarized C-13 MRI Methods for Alzheimer's DiseaseU01EB026412 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GORDON, JEREMY WILLIAM, VIGNERON, DANIEL B · 2019 to 2023
$6.6M
Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy MonitoringR01CA256740 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AGGARWAL, RAHUL, VIGNERON, DANIEL B · 2021 to 2025
$3.3M
Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer PatientsR01CA238379 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOK, ROBERT A, VIGNERON, DANIEL B · 2021 to 2025
$3.3M
Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance PatientsU01CA232320 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOK, ROBERT A, VIGNERON, DANIEL B · 2019 to 2023
$3.2M
Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor AggressivenessR01CA249909 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LARSON, PEDER ERIC ZUFALL, WANG, ZHEN JANE · 2021 to 2025
$3.2M
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASHR01DK115987 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OHLIGER, MICHAEL, VON MORZE, CORNELIUS · 2018 to 2022
$2.1M
Upgrade of an Obsolete 3.35T DNP Polarizer to enable new HP C-13 Technology DevelopmentS10OD025077 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VIGNERON, DANIEL B · 2020 to 2020
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.